Anti-Microbial Savior BioteQ Co., Ltd.(TW:6864)
NT$36.70-1.10 (-2.91%)
TW:6864
Anti-Microbial Savior BioteQ Co., Ltd. financials statements
NT$36.70
At close:-1.10 (-2.91%)
Anti-Microbial Savior BioteQ Co., Ltd. (6864) Income Statement
Anti-Microbial Savior BioteQ Co., Ltd. Income Statement
Last quarter (Q2 2026), Anti-Microbial Savior BioteQ Co., Ltd.'s total revenue was NT$842.00K, an increase of 144.06% from the same quarter last year. In Q2, Anti-Microbial Savior BioteQ Co., Ltd.'s net income was NT$-41.65M. See Anti-Microbial Savior BioteQ Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 706.00K | NT$ 612.00K | NT$ 728.00K | NT$ 2.70M | NT$ 88.00K | |
| NT$ -10.81M | NT$ 144.00K | NT$ -10.18M | NT$ 1.29M | NT$ 47.00K | |
| NT$ 85.18M | NT$ 76.62M | NT$ 49.73M | NT$ 35.11M | NT$ 20.75M | |
| Depreciation and Amortization | NT$ 11.13M | NT$ 10.82M | NT$ 10.51M | NT$ 9.55M | NT$ 7.60M |
| NT$ -84.85M | NT$ -63.67M | NT$ -46.24M | NT$ -30.17M | NT$ -19.62M | |
| NT$ -95.98M | NT$ -76.48M | NT$ -59.91M | NT$ -43.37M | NT$ -28.30M | |
| NT$ 2.39M | NT$ 1.96M | NT$ 3.12M | NT$ 3.56M | NT$ 999.00K | |
| NT$ -93.60M | NT$ -74.52M | NT$ -56.79M | NT$ -39.81M | NT$ -27.31M | |
| NT$ -93.60M | NT$ -74.52M | NT$ -51.78M | NT$ -31.74M | NT$ -22.35M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -2.88 | NT$ -2.46 | NT$ -2.05 | NT$ -1.27 | NT$ -1.18 |
| Diluted EPS | NT$ -2.88 | NT$ -2.46 | NT$ -2.05 | NT$ -1.27 | NT$ -1.18 |
| Weighted Average Shares Outstanding | 32.54M | 30.33M | 25.27M | 25.03M | 18.86M |
| Weighted Average Shares Outstanding (Diluted) | 32.54M | 30.33M | 25.27M | 25.03M | 18.86M |
Currency in TWD

